These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2259867)
1. Amikacin once daily: a new dosing regimen based on drug pharmacokinetics. Maller R; Emanuelsson BM; Isaksson B; Nilsson L Scand J Infect Dis; 1990; 22(5):575-9. PubMed ID: 2259867 [TBL] [Abstract][Full Text] [Related]
2. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis. Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719 [TBL] [Abstract][Full Text] [Related]
3. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens. Marik PE; Havlik I; Monteagudo FS; Lipman J J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148 [TBL] [Abstract][Full Text] [Related]
4. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes. Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120 [TBL] [Abstract][Full Text] [Related]
5. Estimation of once-daily amikacin dose in critically ill adults. Šíma M; Hartinger J; Cikánková T; Slanař O J Chemother; 2018 Feb; 30(1):37-43. PubMed ID: 28950787 [TBL] [Abstract][Full Text] [Related]
6. A study of amikacin given once versus twice daily in serious infections. Maller R; Isaksson B; Nilsson L; Sörén L J Antimicrob Chemother; 1988 Jul; 22(1):75-9. PubMed ID: 3170393 [TBL] [Abstract][Full Text] [Related]
7. Administration of higher doses of amikacin in early stages of sepsis in critically ill patients. Najmeddin F; Ahmadi A; Mahmoudi L; Sadeghi K; Khalili H; Ahmadvand A; Najafi A; Mojtahedzadeh M Acta Med Iran; 2014; 52(9):703-9. PubMed ID: 25325208 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic evaluation of single daily dose amikacin. Van der Auwera P J Antimicrob Chemother; 1991 May; 27 Suppl C():63-71. PubMed ID: 1856147 [TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults. Tod M; Lortholary O; Seytre D; Semaoun R; Uzzan B; Guillevin L; Casassus P; Petitjean O Antimicrob Agents Chemother; 1998 Apr; 42(4):849-56. PubMed ID: 9559795 [TBL] [Abstract][Full Text] [Related]
10. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis. Lugo G; Castañeda-Hernández G Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic dosing of aminoglycosides: a controlled trial. Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133 [TBL] [Abstract][Full Text] [Related]
12. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients. Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of single-dose intravenous amikacin in critically ill patients undergoing slow hemodialysis. Kihara M; Ikeda Y; Takagi N; Fujita H; Shibata K; Masumori S; Shiratori K; Umemura S; Shionoiri H; Ishii M Intensive Care Med; 1995 Apr; 21(4):348-51. PubMed ID: 7650258 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey. Fielding RM; Moon-McDermott L; Lewis RO; Horner MJ Antimicrob Agents Chemother; 1999 Mar; 43(3):503-9. PubMed ID: 10049258 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic variability of amikacin after once-daily and twice-daily dosing regimen in full-term neonates. Vučićević K; Rakonjac Z; Miljković B; Janković B; Prostran M J Pharmacol Sci; 2014; 124(2):138-43. PubMed ID: 24441865 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction. Ghaffari S; Hadi AM; Najmeddin F; Shahrami B; Rouini MR; Najafi A; Mojtahedzadeh M Eur J Hosp Pharm; 2022 Mar; 29(e1):e67-e71. PubMed ID: 34588225 [TBL] [Abstract][Full Text] [Related]
17. Amikacin dosing and monitoring in spinal cord injury patients: variation in clinical practice between spinal injury units and differences in experts' recommendations. Vaidyanathan S; Peloquin C; Wyndaele JJ; Buczynski AZ; Almog Y; Markantonis SL; Jayawardena V; Soni BM; Cannon J; Vidal J ScientificWorldJournal; 2006 Feb; 6():187-99. PubMed ID: 16493523 [TBL] [Abstract][Full Text] [Related]
18. Individualised dosing of amikacin in neonates: a pharmacokinetic/pharmacodynamic analysis. Sherwin CM; Svahn S; Van der Linden A; Broadbent RS; Medlicott NJ; Reith DM Eur J Clin Pharmacol; 2009 Jul; 65(7):705-13. PubMed ID: 19305985 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of once-daily amikacin in elderly patients. Vanhaeverbeek M; Siska G; Herchuelz A J Antimicrob Chemother; 1993 Jan; 31(1):185-7. PubMed ID: 8444669 [No Abstract] [Full Text] [Related]
20. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize Boidin C; Bourguignon L; Cohen S; Roger C; Lefrant JY; Roberts JA; Allaouchiche B; Lepape A; Friggeri A; Goutelle S Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]